下载App
扫码立即下载
下载App
扫码立即下载
公司概况 更多
四环医药控股集团有限公司是一家从事药品业务的香港投资控股公司。该公司主要在中国从事药品研发、制造及销售。其产品覆盖心脑血管、中枢神经系统、新陈代谢、肿瘤及抗感染领域。其产品包括克林澳、安捷利及欧迪美等心脑血管产品以及仁澳、甲硝唑及罗沙替丁等非心脑血管产品。
董事长: 车冯升
所属市场: 香港主板
上市日期: 2010/10/28
富途热股榜
港股美股沪深
交易热度搜索热度资讯热度
名称代码最新价涨跌幅

加载中...

自选
00460 四环医药
1.580-0.030-1.86%
显示同比
不显示
隐藏空行
(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30(FY)2019/12/31
每股指标
每股经营现金净流量(元)
2396.33% 0.0782 -82.95% 0.0285 -97.9% 0.0031 -22.78% 0.1672
每股现金流量净额(元)
136.55% 0.0034 -130.3% -0.0644 -104.79% -0.0093 -29.13% 0.2126
每股营业收入(元)
98.83% 0.2425 -9.15% 0.3093 -38.88% 0.122 -3.38% 0.3405
每股净资产(元)
25.48% 1.2515 1.82% 1.1536 -19.82% 0.9974 -25.02% 1.133
基本每股收益(元)
358.82% 0.078 118.15% 0.059 107.02% 0.017 -265.82% -0.325
稀释每股收益(元)
352.94% 0.077 118.15% 0.059 107.02% 0.017 -265.82% -0.325
盈利能力
销售毛利率
3.2% 76.925% -2.27% 77.690% -9.43% 74.540% -2.52% 79.492%
经营利润率
55.45% 46.453% 137.56% 31.942% 128.93% 29.884% -222.45% -85.032%
销售净利率
127.76% 31.156% 121.75% 20.773% 111.58% 13.680% -265.92% -95.509%
税前利润率
49.98% 42.967% 136.37% 31.078% 127.58% 28.650% -223.89% -85.450%
净资产收益率(ROE)
296.69% 6.460% 121.17% 5.197% 109.25% 1.629% -282.82% -24.554%
总资产净利率(ROA)
288.69% 4.496% 119.64% 3.809% 108.39% 1.157% -277.87% -19.392%
收益质量
营业利润/利润总额
3.65% 108.112% -- 102.779% -- 104.308% -- --
税项/利润总额
-37.76% 27.489% -- 28.601% -- 44.164% -- --
经营活动产生的现金流量净额/营业收入
1155.29% 32.251% -81.23% 9.217% -96.57% 2.569% -20.08% 49.112%
资本结构
资产负债率
-20.39% 25.347% 13.46% 23.729% 44.16% 31.838% 21.01% 20.914%
权益乘数
-4.45% 1.4534 8.46% 1.4193 14.52% 1.521 6.01% 1.3086
产权比率
-27.31% 33.954% 17.64% 31.112% 64.78% 46.710% 26.57% 26.445%
流动资产/总资产
-5.37% 50.099% -2.11% 49.097% 9.09% 52.940% 34.09% 50.155%
非流动资产/总资产
6.04% 49.901% 2.12% 50.903% -8.57% 47.060% -20.37% 49.845%
流动负债/负债合计
-20.88% 71.894% -8.2% 78.931% 2.06% 90.862% 2.07% 85.986%
非流动负债/负债合计
207.57% 28.106% 50.34% 21.069% -16.73% 9.138% -11.05% 14.014%
偿债能力
流动比率
50.23% 2.7492 -6.01% 2.6213 -25.85% 1.83 8.57% 2.7889
速动比率
47.72% 2.5322 -7.26% 2.4184 -26.53% 1.7141 7.1% 2.6078
营业利润/流动负债
309.23% 0.3398 129.67% 0.3222 113.09% 0.083 -220.52% -1.0858
经营活动产生的现金流量净额/流动负债
3204.52% 0.2359 -85.18% 0.093 -98.45% 0.0071 -21.34% 0.6272
归属母公司股东的权益/负债合计
31.45% 2.7144 -18.74% 2.9692 -39.43% 2.065 -22.05% 3.6538
经营活动产生的现金流量净额/负债合计
2514.89% 0.1696 -86.39% 0.0734 -98.42% 0.0065 -19.71% 0.5393
营业利润/负债合计
223.8% 0.2443 127.24% 0.2543 113.36% 0.0755 -223.01% -0.9337
营运能力
存货周转率(次)
33.09% 0.8335 -24.28% 1.2485 -28.89% 0.6263 -17.22% 1.6488
流动资产周转率(次)
79.19% 0.2826 -15.36% 0.3998 -40.74% 0.1577 -12.65% 0.4723
固定资产周转率(次)
64.53% 0.6188 -15.31% 0.8771 -37.04% 0.3761 -5% 1.0357
总资产周转率(次)
72.45% 0.1402 -2.48% 0.1983 -28.31% 0.0813 3.56% 0.2033
成长能力
营业收入(近3年增长率)
268.15% 51.173% -20.08% -11.250% -286.21% -30.433% 20.06% -9.369%
毛利(近3年增长率)
268.51% 44.923% -197.14% -4.712% -161.62% -26.659% 107.65% 4.851%
营业利润(近3年增长率)
92.83% -4.956% 74.96% -53.893% 77.07% -69.074% -670.29% -215.200%
税前利润(近3年增长率)
86.17% -9.850% 73.81% -56.199% 75.3% -71.213% -567.77% -214.614%
净利润(近3年增长率)
72.01% -23.422% 75.1% -65.771% 77.11% -83.691% -1140.85% -264.156%
归属母公司股东的净利润(近3年增长率)
77.02% -19.089% 74.08% -67.691% 77.33% -83.083% -956.61% -261.194%
资产总计(近3年增长率)
82.58% -1.337% -261.31% -5.095% -416.01% -7.673% -84.31% 3.159%
归属母公司股东的权益(近3年增长率)
35.27% -14.760% -50% -17.803% -108.72% -22.801% -247.27% -11.869%
股东权益(近3年增长率)
52.03% -9.821% -40.99% -13.211% -141.29% -20.473% -199.77% -9.370%
负债合计(近3年增长率)
-10.74% 36.480% -69.27% 35.690% -46.79% 40.868% -8.2% 116.149%
基本每股收益(近3年增长率)
77.5% -18.750% 75.1% -67.935% 78.72% -83.333% -1446.28% -272.872%
每股净资产(近3年增长率)
35.91% -14.586% -69.84% -17.756% -653.35% -22.757% -157.29% -10.455%
其他
货币单位
港元港元港元港元

Q6、Q9、FY为累计季报:Q6 为中期报告;Q9 为第三季报;FY为年报。

环比数据来源于季报,环比 = (本期 - 上期)/上期 * 100%

回到顶部